Crista Galli Ventures

Crista Galli Ventures is a venture capital firm investing in early-stage healthtech companies across Europe. Their focus is on Seed and Series A stages, providing funding up to £500k at Seed or first ticket and up to £3m at Series A or second ticket. They also invest in exceptional pre-Seed founders through Crista Galli LABS. Their investment areas include healthtech, deeptech, digital health, and personalized healthcare. The firm is led by Dr. Fiona Pathiraja, a former NHS radiologist, and Søren Fryland Møller, an experienced investor. They are advised by a strong group of trusted advisors, many of whom are prominent in healthcare and finance, providing access to global networks. Crista Galli Ventures is based in London, United Kingdom, and operates across Europe, including countries such as Denmark, Sweden, Spain, Germany, France, the Netherlands, Italy, Norway, Finland, Belgium, Austria, Switzerland, Poland, Portugal, Ireland, Greece, the Czech Republic, Hungary, and Romania. Their portfolio includes companies like 52 North Health, Arthronica, CardiaTec Biosciences, PTC Therapeutics, QUIBIM S.L., Quibim, and Subtle Medical. They are one of the only healthtech funds worldwide led by an experienced doctor, bringing a unique combination of front-line health experience and honed financial acumen to the table. They are free from the traditional venture capital model, allowing them to invest in an agile way while thinking in the long-term horizon. They are at the start of an exciting new chapter to shape the future of healthcare in new ways.

Crista Galli Ventures is a venture capital firm investing in early-stage healthtech companies across Europe. Their focus is on Seed and Series A stages, providing funding up to £500k at Seed or first ticket and up to £3m at Series A or second ticket. They also invest in exceptional pre-Seed founders through Crista Galli LABS. Their investment areas include healthtech, deeptech, digital health, and personalized healthcare. The firm is led by Dr. Fiona Pathiraja, a former NHS radiologist, and Søren Fryland Møller, an experienced investor. They are advised by a strong group of trusted advisors, many of whom are prominent in healthcare and finance, providing access to global networks. Crista Galli Ventures is based in London, United Kingdom, and operates across Europe, including countries such as Denmark, Sweden, Spain, Germany, France, the Netherlands, Italy, Norway, Finland, Belgium, Austria, Switzerland, Poland, Portugal, Ireland, Greece, the Czech Republic, Hungary, and Romania. Their portfolio includes companies like 52 North Health, Arthronica, CardiaTec Biosciences, PTC Therapeutics, QUIBIM S.L., Quibim, and Subtle Medical. They are one of the only healthtech funds worldwide led by an experienced doctor, bringing a unique combination of front-line health experience and honed financial acumen to the table. They are free from the traditional venture capital model, allowing them to invest in an agile way while thinking in the long-term horizon. They are at the start of an exciting new chapter to shape the future of healthcare in new ways.

Crista Galli Ventures is a venture capital firm investing in early-stage healthtech companies across Europe. Their focus is on Seed and Series A stages, providing funding up to £500k at Seed or first ticket and up to £3m at Series A or second ticket. They also invest in exceptional pre-Seed founders through Crista Galli LABS. Their investment areas include healthtech, deeptech, digital health, and personalized healthcare. The firm is led by Dr. Fiona Pathiraja, a former NHS radiologist, and Søren Fryland Møller, an experienced investor. They are advised by a strong group of trusted advisors, many of whom are prominent in healthcare and finance, providing access to global networks. Crista Galli Ventures is based in London, United Kingdom, and operates across Europe, including countries such as Denmark, Sweden, Spain, Germany, France, the Netherlands, Italy, Norway, Finland, Belgium, Austria, Switzerland, Poland, Portugal, Ireland, Greece, the Czech Republic, Hungary, and Romania. Their portfolio includes companies like 52 North Health, Arthronica, CardiaTec Biosciences, PTC Therapeutics, QUIBIM S.L., Quibim, and Subtle Medical. They are one of the only healthtech funds worldwide led by an experienced doctor, bringing a unique combination of front-line health experience and honed financial acumen to the table. They are free from the traditional venture capital model, allowing them to invest in an agile way while thinking in the long-term horizon. They are at the start of an exciting new chapter to shape the future of healthcare in new ways.